Target intelligence / Profile preview

Long intergenic non-protein coding RNA 622 (LINC00622)

Target
LINC00622
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 622 (LINC00622) is a long non-coding RNA (lncRNA), more specifically, a long intergenic non-coding RNA (lincRNA), which is transcribed from a genomic locus that does not overlap annotated protein-coding genes. LINC00622, like other lincRNAs, does not code for a protein but participates in the regulation of gene expression at the transcriptional and post-transcriptional level, often through modulation of chromatin structure, enhancer activity, and other regulatory mechanisms. Functional studies indicate roles for LINC00622 in regulating autophagic cell death and gene networks involved in proliferation and survival, with potential involvement in cancer biology by promoting or repressing tumorigenic pathways. As with most lincRNAs, LINC00622 is not considered a classic therapeutic target (such as a receptor or enzyme) and currently has no known direct interacting drugs or established mechanism-of-action for pharmacological modulation. Its principal importance lies in its function as a gene expression regulator and possible implication in human diseases, especially cancer, but it is not yet established as a biomarker or therapeutic target in clinical settings.

Other names
LINC00622
02

Biological functions

Regulation of gene expressionModulation of autophagy and cell death pathwaysChromatin remodellingTranscriptional regulation in cis or trans
03

Disease associations

Cancer (roles in tumorigenesis and potentially as a cancer biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 622 (LINC00622).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 622 (LINC00622).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call